Literature DB >> 16116185

Effects of castration on thymocyte development in two different models of thymic involution.

Tracy S P Heng1, Gabrielle L Goldberg, Daniel H D Gray, Jayne S Sutherland, Ann P Chidgey, Richard L Boyd.   

Abstract

Age-associated thymic involution is accompanied by decreased thymic output. This adversely affects general immune competence and T cell recovery following cytoreductive treatments such as chemotherapy. A causal link between increasing sex steroids and age-related thymic atrophy is well established. Although castration has been demonstrated to regenerate the atrophied thymus, little is known about how this is initiated or the kinetics of thymocyte regeneration. The present study shows that although castration impacts globally across thymocyte development in middle-aged mice, the regenerative effects are initiated in the immature triple-negative compartment and early T lineage progenitors (ETP). Specifically, there was a reduction in number of ETP with age, which was restored following castration. There was, however, no change in ETP reconstitution potential in ETP at this age or following castration. Furthermore, in a chemotherapy-induced model of thymic involution, we demonstrate castration enhances intrathymic proliferation and promotes differentiation through the triple-negative program. Clinically, reversible sex steroid ablation is achieved hormonally, and thus presents a means of ameliorating immune inadequacies, for example, following chemotherapy for bone marrow transplantation. By improving our understanding of the kinetics of thymic recovery, this study will allow more appropriate timing of therapy to achieve maximal reconstitution, especially in the elderly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116185     DOI: 10.4049/jimmunol.175.5.2982

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  87 in total

1.  The origin and implication of thymic involution.

Authors:  Danielle Aw; Donald B Palmer
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

2.  MCL1 increases primitive thymocyte viability in female mice and promotes thymic expansion into adulthood.

Authors:  Jingang Gui; Amanda J Morales; Sophie E Maxey; Katherine A Bessette; Nora R Ratcliffe; John A Kelly; Ruth W Craig
Journal:  Int Immunol       Date:  2011-09-21       Impact factor: 4.823

3.  Thymus Size and Age-related Thymic Involution: Early Programming, Sexual Dimorphism, Progenitors and Stroma.

Authors:  Jingang Gui; Lisa Maria Mustachio; Dong-Ming Su; Ruth W Craig
Journal:  Aging Dis       Date:  2012-03-14       Impact factor: 6.745

4.  Regeneration of dendritic cells in aged mice.

Authors:  Serani L H van Dommelen; Alexandra Rizzitelli; Ann Chidgey; Richard Boyd; Ken Shortman; Li Wu
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

Review 5.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

Review 6.  Cell Therapy Strategies to Combat Immunosenescence.

Authors:  Elizabeth C Stahl; Bryan N Brown
Journal:  Organogenesis       Date:  2015-11-20       Impact factor: 2.500

Review 7.  Aging, B lymphopoiesis, and patterns of leukemogenesis.

Authors:  Robert A J Signer; Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Exp Gerontol       Date:  2006-12-20       Impact factor: 4.032

Review 8.  Immunosenescence: emerging challenges for an ageing population.

Authors:  Danielle Aw; Alberto B Silva; Donald B Palmer
Journal:  Immunology       Date:  2007-02-15       Impact factor: 7.397

9.  Twisting immune responses for allogeneic stem cell therapy.

Authors:  Shengwen Calvin Li; Jiang F Zhong
Journal:  World J Stem Cells       Date:  2009-12-31       Impact factor: 5.326

Review 10.  Rejuvenation of the aging T cell compartment.

Authors:  Amanda M Holland; Marcel R M van den Brink
Journal:  Curr Opin Immunol       Date:  2009-07-14       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.